ReviewCancer medicine2022
Checkpoint inhibitor/interleukin-based combination therapy of cancer.
Keywan Mortezaee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it
ReviewCancer medicine2022
Keywan Mortezaee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.